21 May 2013
Keywords: heptovir, approved, canada, glaxo, wellcome, biochem, pharma
Article | 02 December 1998
Glaxo Wellcome and BioChem Pharma's Heptovir (lamivudine) has beenapproved by the Therapeutic Products Program of Health Canada. The
drug is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 December 1998
3 December 1998
20 May 2013
© 2013 thepharmaletter.com